Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 6, 2002, Pages 419-426

  Kim, B ^a   Ryu, J ^a   Kim, Y ^a,b   Woo, J ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BILIARY TRACT DISEASE; CHILD; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RATE; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; NONHUMAN; OUTCOMES RESEARCH; PANCREAS DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEPTIC SHOCK; SOLID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0036314897     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0738-9     Document Type: Article

References (33)

1. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors
2. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: The effects of antimicrobial therapy
3. Klebsiella bacteraemia: A report of 101 cases from National University Hospital, Singapore
4. Klebsiella bacteremia: An analysis of 100 episodes
5. Epidemiology of Klebsiella bacteraemia: A case control study using Escherichia coli bacteraemia as control
6. Klebsiella bacteraemia: Community versus nosocomial infection
7. Klebsiella bacteremia: A review of 196 episodes during a decade (1980-1989)
8. Prospective observational study of Klebsiella bacteremia in 230 patients: Outcome for antibiotic combinations versus monotherapy
9. Bacteremia due to Klebsiella oxytoca: Clinical features of patients and antimicrobial susceptibilities of the isolates
10. Klebsiella infection in a neonatal intensive care unit: Role of bacteriological surveillance
11. An outbreak of Klebsiella oxytoca septicemia associated with the use of invasive blood pressure monitoring equipment
12. Application of pulsed-field gel electrophoresis in an outbreak of infection due to Klebsiella oxytoca
13. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
14. Extended spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns
15. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations
16. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
17. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients
18. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations
19. Klebsiella species: Antimicrobial susceptibilities, bactericidal kinetics, and in vitro inactivation of beta-lactam agents
20. Hepatolithiasis: Present status
21. Beta-lactamases in laboratory and clinical resistance
22. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca
23. Klebsiella oxytoca: Resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase
24. A survey of beta-lactamases from 618 isolates of Klebsiella spp.
25. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in southern and western Europe in 1997-1998
26. Present situation of antimicrobial resistance in Korea
27. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: Prevalence of SHV-12 and SHV-2a in Korea
28. Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence of TEM-52 in Korea
29. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics
30. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)
31. Interpretative reading: Recognizing the unusual and inferring resistance mechanisms from resistance phenotypes
32. Cephalosporin resistance in strains of Klebsiella oxytoca isolated during antibiotic therapy